If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

First Interim Dividend

20 Dec 2021 15:09

RNS Number : 2455W
Aberdeen Latin American Inc Fd Ltd
20 December 2021
 

Aberdeen Latin American Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

20 December 2021

 

First Interim Dividend

In accordance with the Company's stated aim to pay a minimum dividend of 3.5p pence per share for the year, the Board of Aberdeen Latin American Income Fund Limited (the "Company") has today declared a first interim dividend of 0.875p per Ordinary share (2021: 0.875p) in respect of the year ending 31 August 2022 payable on 28 January 2022 to Ordinary shareholders on the register at close of business on 7 January 2022 (ex-dividend date 6 January 2022).

The Board is aware of the importance of income to the Company's shareholders and has maintained the dividend at the same rate as last year.

The Board continually assesses the impact on earnings resulting from the ongoing Covid-19 pandemic. Latin American governments continue to try to manage the effect of Covid-19 on their economies and our investee companies are seeking to manage volatile trading conditions as inflationary pressures mount. The Directors have previously noted the revenue reserve that has been built up and one of the benefits of the investment company structure is the ability to use accumulated reserves to maintain distributions to shareholders where there is a shortfall in earnings.

The Board's intention is that interim dividends will continue to be paid quarterly, subject to cash levels and reserves being sufficient to allow the Company to do so. The Directors place great emphasis on exercising prudence, particularly in these uncertain times, and on ensuring that the robustness of the Company's balance sheet is maintained. The Board continues to monitor closely the ongoing impact of Covid-19 and its variants and the success of the vaccine roll-out, together with its ramifications for the region, valuations and recurring earnings, while taking into account the income requirements of its shareholders, and will keep future dividend policy under review. 

abrdn Capital International Limited

Manager and Company Secretary

 

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBUBDDIGDDGBG
Date   Source Headline
4th Feb 20213:01 pmRNSMonth End Net Asset Value(s)
4th Feb 202111:53 amRNSNet Asset Value(s)
4th Feb 20219:14 amRNSHolding(s) in Company
3rd Feb 202111:04 amRNSNet Asset Value(s)
2nd Feb 20211:34 pmRNSNet Asset Value(s)
1st Feb 20212:41 pmRNSGearing disclosure
29th Jan 202112:32 pmRNSNet Asset Value(s)
28th Jan 202111:40 amRNSNet Asset Value(s)
27th Jan 202111:44 amRNSNet Asset Value(s)
26th Jan 20211:01 pmRNSNet Asset Value(s)
25th Jan 20212:33 pmRNSGearing disclosure
25th Jan 202112:33 pmRNSNet Asset Value(s)
22nd Jan 202111:42 amRNSNet Asset Value(s)
21st Jan 202111:39 amRNSNet Asset Value(s)
20th Jan 202111:00 amRNSNet Asset Value(s)
19th Jan 202110:51 amRNSNet Asset Value(s)
18th Jan 202112:57 pmRNSGearing disclosure
18th Jan 202112:39 pmRNSNet Asset Value(s)
15th Jan 202111:47 amRNSNet Asset Value(s)
14th Jan 202111:41 amRNSNet Asset Value(s)
14th Jan 202110:45 amRNSPortfolio disclosure
13th Jan 202111:48 amRNSNet Asset Value(s)
12th Jan 202111:09 amRNSNet Asset Value(s)
11th Jan 202111:50 amRNSGearing disclosure
11th Jan 202111:14 amRNSNet Asset Value(s)
8th Jan 202111:06 amRNSNet Asset Value(s)
7th Jan 20213:12 pmRNSMonth End Net Asset Value(s)
7th Jan 202111:27 amRNSNet Asset Value(s)
6th Jan 202112:20 pmRNSNet Asset Value(s)
5th Jan 202111:29 amRNSNet Asset Value(s)
4th Jan 20212:45 pmRNSGearing disclosure
31st Dec 202012:36 pmRNSNet Asset Value(s)
30th Dec 202011:05 amRNSNet Asset Value(s)
29th Dec 20202:31 pmRNSGearing Disclosure
29th Dec 202012:09 pmRNSNet Asset Value(s)
24th Dec 202011:31 amRNSNet Asset Value(s)
23rd Dec 202011:47 amRNSNet Asset Value(s)
22nd Dec 202011:34 amRNSNet Asset Value(s)
21st Dec 20204:40 pmRNSSecond Price Monitoring Extn
21st Dec 20204:35 pmRNSPrice Monitoring Extension
21st Dec 20202:35 pmRNSGearing disclosure
21st Dec 202011:53 amRNSNet Asset Value(s)
18th Dec 202012:09 pmRNSNet Asset Value(s)
17th Dec 202012:12 pmRNSNet Asset Value(s)
16th Dec 202010:56 amRNSNet Asset Value(s)
15th Dec 202011:14 amRNSNet Asset Value(s)
14th Dec 20203:46 pmRNSGearing disclosure
14th Dec 202012:20 pmRNSNet Asset Value(s)
14th Dec 202011:10 amRNSPortfolio disclosure
11th Dec 202012:34 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.